Key result
Microalbuminuria linked to ~6-fold higher CVD risk in patients with acute chest pain.
Why the study?
Microalbuminuria and C-reactive protein are emerging markers related to cardiovascular disease events in patients with acute chest pain, but their predictive value requires further evaluation.
Do elevated levels of CRP and microalbuminuria predict the presence of cardiovascular disease in patients presenting with acute chest pain?
Observational
Do elevated levels of CRP and microalbuminuria predict the presence of cardiovascular disease in patients presenting with acute chest pain?
CRP and microalbuminuria may serve as useful biomarkers for screening and identifying cardiovascular disease in patients presenting with acute chest pain.
Answers are grounded in this paper and cite their sources.
Microalbuminuria may aid CVD risk screening; leaves open prospective validation with CRP in larger cohorts.
Microalbuminuria is a risk factor for cardiovascular disease. It is gaining importance as a marker of atherogenic milieu and indicates the target organ damage and can be a valuable tool in screening and identification of patients with cardiovascular disease. Markers of inflammation, such as C-reactive protein (CRP), were found to be related to cardiovascular disease (CVD) events in patients with chest pain. In addition, recent studies have shown that, in the case of atherosclerosis, increased levels of CRP, reflects inflammatory condition of vessel wall. In the present study, CRP and microalbuminuria were estimated in patients of acute chest pain. The patients were divided into two study groups (gp-1 patients of chest pain with CVD and gp-2 patients of chest pain of causes other than CVD) along with one healthy control group. It was found that microalbuminuria was higher in CVD patients (RR = 6.250,95% CI 2.346-16.45,P < 0.05) and also CRP was much higher in CVD patients (RR = 13.667,95% CI 4.528-41.253, P < 0.05) as compared to other two groups. Sensitivity, specificity and positive predictive value of CRP and microalbuminuria were also higher in gp-1 (CVD) patients as compared to other two groups. Therefore, CRP and microalbuminuria can be used as important biomarkers in screening CVD.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2013) conducted an observational in Acute chest pain. Microalbuminuria and C-reactive protein vs. Chest pain of non-CVD causes and healthy controls was evaluated on Cardiovascular disease (CVD) (RR 6.250, 95% CI 2.346-16.45, p=< 0.05). Microalbuminuria and C-reactive protein were associated with cardiovascular disease in patients with acute chest pain.
Synapse has enriched 10 related papers. Consider them for comparative context: